← Browse by Condition
Medical Condition
ulcerative colitis uc
Total Trials
8
Recruiting Now
8
Trial Phases
Phase 2, Phase 1, Phase 2
NCT07442045
Recruiting
Real-World Effectiveness and Safety of Upadacitinib Plus Vedolizumab vs Upadacitinib Monotherapy During Induction in Moderate-to-Severe Ulcerative Colitis
Enrollment
150 pts
Location
China
Sponsor
Sixth Affiliated Hospital, Sun...
NCT06850727 Phase 2
Recruiting
Safety and Efficacy of OD-07656 and of Subsequent Vedolizumab Therapy in Moderately to Severely Active Ulcerative Colitis
Enrollment
57 pts
Location
Australia, Austria, ...
Sponsor
Odyssey Therapeutics
NCT06758024
Recruiting
PROactive and Early Infliximab Monitoring and OPTimization in Inflammatory Bowel Disease
Enrollment
72 pts
Location
Chile
Sponsor
Pontificia Universidad Catolic...
NCT06095596
Recruiting
Efficacy and Safety of Vedolizumab Combined With Upadacitinib in Patients With Ulcerative Colitis
Enrollment
334 pts
Location
China
Sponsor
Sixth Affiliated Hospital, Sun...
NCT06655415
Recruiting
Family Members At INcreased-risk for Developing Inflammatory Bowel Disease
Enrollment
50 pts
Location
United States
Sponsor
Massachusetts General Hospital
NCT06862843
Recruiting
Study on Eating Habits and Association with "omic" Profiles in Families with a Subject Affected by a Chronic Immune-mediated Inflammatory Pathology. Observational Multicenter Study.
Enrollment
90 pts
Location
Italy
Sponsor
Meyer Children's Hospital IRCC...
NCT06619990 Phase 1, Phase 2
Recruiting
Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis
Enrollment
270 pts
Location
United States, Austr...
Sponsor
Xencor, Inc.
NCT07195123
Recruiting
Evaluation of the SMART IBD App in Pediatric IBD
Enrollment
70 pts
Location
United States
Sponsor
Children's Hospital Medical Ce...